Neogenomics Inc
NEO
Revenue
67.75M
▲4.32M▲6.82%
3 Months ChangeAssets
1.64B
▲2.94M▲0.1791%
3 Months ChangeLiabilities
727.39M
▲10.46M▲1.46%
3 Months ChangeFree Cash Flow
-31.50M
▼-8.88M▼-39.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-07-30
Form 10-Q
ID: 0001077183-24-000109
2024-07-29
Form 8-K
ID: 0001077183-24-000106
2024-05-24
Form 8-K
ID: 0001077183-24-000081
2024-04-30
Form 10-Q
ID: 0001077183-24-000054
2024-04-30
Form 8-K
ID: 0001077183-24-000052
2024-04-18
Form 8-K
ID: 0001077183-24-000048
2024-02-23
Form 8-K
ID: 0001077183-24-000016
2024-02-20
Form 8-K
ID: 0001077183-24-000009
2023-11-06
Form 10-Q
ID: 0001077183-23-000138
2023-11-06
Form 8-K
ID: 0001077183-23-000136